Obstructive lung disease does not increase lung cancer mortality among female never-smokers in Hong Kong

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 546-552

  Leung, Chi Chiu ^a   Lam, T H ^b   Yew, W W ^c   Law, W S ^a   Tam, C M ^a   Chang, K C ^a   McGhee, S ^a   Tam, S Y ^a   Chan, K F ^a  

^a Department of Health   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

Gender; Lung cancer; Obstructive lung disease; Tobacco

Indexed keywords

AGED; ARTICLE; ASTHMA; CANCER MORTALITY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; FEMALE; FOLLOW-UP STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HONG KONG; HUMANS; LUNG NEOPLASMS; MALE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL;

EID: 84858634454     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0573     Document Type: Article

References (36)

1. Doll R, Hill A B. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950; 2: 739-748.
2. Liu B Q, Peto R, Chen Z M, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. Br Med J 1998; 317: 1411-1422. (Pubitemid 28522092)
3. Alavanja M C R, Brownson R C, Boice J D Jr, Hock E. Pre-existing lung disease and lung cancer among non-smoking women. Am J Epidemiol 1992; 136: 623-632.
4. Wu A H, Fontham E T, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995; 141: 1023-1032.
5. Mayne S T, Buenconsejo J, Janerich D T. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149: 13-20. (Pubitemid 29028857)
6. Brenner A V, Wang Z, Kleinerman R A, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 2001; 30: 118-124. (Pubitemid 32203799)
7. Littman A J, Thornquist M D, White E, Jackson L A, Goodman G E, Vaughan T L. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 2004; 15: 819-827. (Pubitemid 39335578)
8. Turner M C, Chen Y, Krewski D, Calle E E, Thun M J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never-smokers. Am J Respir Crit Care Med 2007; 176: 285-290. (Pubitemid 47195879)
9. Purdue M P, Gold L, Järvholm B, Alavanja M C, Ward M H, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007; 62: 51-56. (Pubitemid 46101766)
10. Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: a prospective cohort study. Thorax 1997; 52: 49-54. (Pubitemid 27047225)
11. Brown D W, Young K E, Anda R F, Giles W H. Asthma and risk of death from lung cancer: NHANES II Mortality Study. J Asthma 2005; 42: 597-600. (Pubitemid 41765312)
12. Turner M C, Chen Y, Krewski D, Ghadirian P, Thun M J, Calle E E. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 2005; 162: 212-221. (Pubitemid 41373525)
13. González-Pérez A, Fernández-Vidaurre C, Rueda A, Rivero E, García Rodríguez L A. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 2006; 15: 131-138.
14. Spira A, Beane J E, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007; 13: 361-366. (Pubitemid 46376687)
15. Massion P P, Zou Y, Chen H, et al. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med 2008; 178: 1164-1172.
16. Mannino D M, Buist A S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773. (Pubitemid 47321908)
17. Soriano J B, Davis K J, Coleman B, Visick G, Mannino D, Pride N B. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481. (Pubitemid 37000122)
18. Hsu L H, Chu N M, Liu C C, et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor? Lung Cancer 2009; 66: 262-267.
19. Chang J W, Asamura H, Kawachi R, Watanabe S. Gender d ifference in survival of resected non-small cell lung cancer: histology-related phenomenon? J Thorac Cardiovasc Surg 2009; 137: 807-812.
20. Thun M J, Hannan L M, Adams-Campbell L L, et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 2008; 5: e185.
21. WHO expert consultation: appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
22. Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 2009; 4: e7380.
23. Eberly L E, Ockene J, Sherwin R, Yang L, Kuller L; Multiple Risk Factor Intervention Trial Research Group. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. Int J Epidemiol 2003; 32: 592-599. (Pubitemid 37039014)
24. Loganathan R S, Stover D E, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129: 1305-1312.
25. Schwartz A G, Cote M L, Wenzlaff A S, et al. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 2009; 4: 291-299.
26. Parimon T, Chien J W, Bryson C L, McDonell M B, Udris E M, Au D H. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 712-719. (Pubitemid 46536487)
27. Kiri V A, Fabbri L M, Davis K J, Soriano J B. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Respir Med 2009; 103: 85-90.
28. van den Berg R M, van Tinteren H, van Zandwijk N, et al. The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium. Am J Respir Crit Care Med 2007; 175: 1061-1065.
29. Lam S, leRiche J C, McWilliams A, et al. A randomized phase IIB trial of Pulmicort Turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res 2004; 10: 6502-6511. (Pubitemid 39346545)
30. Calverley P M, Anderson J A, Celli B, et al.; TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
31. Ma B B, Hui E P, Mok T S. Population-based differences in treatment outcome following anticancer drug therapies. Lancet Oncol 2010; 11: 75-84.
32. Mok T S, Wu Y L, Thongprasert S, et al. Gefitinib or carboplatin- paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947-957.
33. Planchard D, Loriot Y, Goubar A, Commo F, Soria J C. Differential expression of biomarkers in men and women. Semin Oncol 2009; 36: 553-565.
34. Ko F W, Woo J, Tam W, et al. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J 2008; 32: 1472-1478.
35. Marcus P M, Bergstralh E J, Fagerstrom R M, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92: 1308-1316. (Pubitemid 30660590)
36. Dubey S, Powell C A. Update in lung cancer 2007. Am J Respir Crit Care Med 2008; 177: 941-946. (Pubitemid 351717586)